Genetic variants associated with cisplatin-induced hearing loss

被引:3
|
作者
Pussegoda, K. A. [1 ]
机构
[1] Ctr Mol Med & Therapeut, Dept Med Genet, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada
关键词
OTOTOXICITY;
D O I
10.1111/j.1399-0004.2010.01414_2.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:33 / U2
页数:3
相关论文
共 50 条
  • [41] Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss
    Sheth, Sandeep
    Sheehan, Kelly
    Dhukhwa, Asmita
    Al Aameri, Raheem F. H.
    Mamillapalli, Chaitanya
    Mukherjea, Debashree
    Rybak, Leonard P.
    Ramkumar, Vickram
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [42] Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss
    Brock, P. R.
    Maibach, R.
    Childs, M.
    Rajput, K.
    Roebuck, D.
    Sullivan, M. J.
    Laithier, V.
    Ronghe, M.
    Dall'Igna, P.
    Hiyama, E.
    Brichard, B.
    Skeen, J.
    Mateos, M. E.
    Capra, M.
    Rangaswami, A. A.
    Ansari, M.
    Rechnitzer, C.
    Veal, G. J.
    Covezzoli, A.
    Brugieres, L.
    Perilongo, G.
    Czauderna, P.
    Morland, B.
    Neuwelt, E. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25): : 2376 - 2385
  • [43] Interventions for cisplatin-induced hearing loss in children and adolescents with cancer
    Freyer, David R.
    Brock, Penelope
    Knight, Kristin
    Reaman, Gregory
    Cabral, Sandra
    Robinson, Paula D.
    Sung, Lillian
    LANCET CHILD & ADOLESCENT HEALTH, 2019, 3 (08): : 578 - 584
  • [44] Correction: Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss
    Heng Xu
    Giles W Robinson
    Jie Huang
    Joshua Yew-Suang Lim
    Hui Zhang
    Johnnie K Bass
    Alberto Broniscer
    Murali Chintagumpala
    Ute Bartels
    Sri Gururangan
    Tim Hassall
    Michael Fisher
    Richard Cohn
    Tetsuji Yamashita
    Tal Teitz
    Jian Zuo
    Arzu Onar-Thomas
    Amar Gajjar
    Clinton F Stewart
    Jun J Yang
    Nature Genetics, 2015, 47 : 423 - 423
  • [45] Erratum: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
    Colin J D Ross
    Hagit Katzov-Eckert
    Marie-Pierre Dubé
    Beth Brooks
    S Rod Rassekh
    Amina Barhdadi
    Yassamin Feroz-Zada
    Henk Visscher
    Andrew M K Brown
    Michael J Rieder
    Paul C Rogers
    Michael S Phillips
    Bruce C Carleton
    Michael R Hayden
    Nature Genetics, 2013, 45 : 578 - 578
  • [46] Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss
    Lee, Chang Ho
    Kim, Kyung Woon
    Lee, So Min
    Kim, So Young
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 12
  • [47] Autophagy-dependent ferroptosis contributes to cisplatin-induced hearing loss
    Jian, Bingquan
    Pang, Jiaqi
    Xiong, Hao
    Zhang, Weijian
    Zhan, Ting
    Su, Zhongwu
    Lin, Hanqing
    Zhang, Huasong
    He, Wuhui
    Zheng, Yiqing
    TOXICOLOGY LETTERS, 2021, 350 : 249 - 260
  • [48] Cisplatin-induced hearing loss does not correlate with intracellular platinum concentration
    Ramirez-Camacho, R.
    Fernandez, D. Esteban
    Verdaguer, J. M.
    Gomez, M. M. Gomez
    Trinidad, A.
    Garcia-Berrocal, J. R.
    Corvillo, M. A. Palacios
    ACTA OTO-LARYNGOLOGICA, 2008, 128 (05) : 505 - 509
  • [49] Prevention of cisplatin-induced hearing-loss by sodium thiosulfate in medulloblastoma
    Harao, Takuro
    Yamada, Ai
    Kinoshita, Mariko
    Kamimura, Sachiyo
    Moritake, Hiroshi
    PEDIATRICS INTERNATIONAL, 2020, 62 (10) : 1204 - 1206
  • [50] IMPACT OF GENTAMICIN USE ON CISPLATIN-INDUCED HEARING LOSS IN PATIENTS WITH OSTEOSARCOMA
    Zehnhoff-Dinnesen, A. Am
    Richter, K.
    Parfitt, R.
    Deuster, D.
    Roessig, C.
    Lanvers-Kaminsky, C.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S263 - S263